Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thyroid hormone receptor beta 1 (TRβ1) is a member of the nuclear hormone receptor superfamily, encoded by the THRB gene. It functions as a ligand-dependent transcription factor activated by binding thyroid hormones, especially triiodothyronine (T3), regulating the transcription of numerous genes involved in development, metabolism, and differentiation[3][1][6][2]. TRβ1 plays major roles in the central nervous system, auditory and visual sensory systems, as well as in overall metabolic regulation[7][9][5]. Mutations in the gene or abnormal function are associated with generalized thyroid hormone resistance, certain cancers, metabolic and neurological disorders[6][3][5]. TRβ1 is a prominent therapeutic target for novel thyroid hormone mimetics aiming to treat metabolic disorders like nonalcoholic steatohepatitis (NASH) while minimizing cardiac and bone side effects[5].
Agonist binding leads to activation of gene transcription via thyroid hormone response elements Repressors block transcription in the absence of ligand Some synthetic agonists selectively activate TRβ1
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thyroid hormone receptor beta 1 (TRβ1).